Vera Therapeutics, Inc. Class A Common Stock (NASDAQ: VERA) last traded at $29.88, up 0.50% on the session. The quote above updates while this page is open; the figures below are drawn from Vera Therapeutics, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Vera Therapeutics, Inc. Class A Common Stock trades on NASDAQ under the ticker VERA. Its market capitalisation is $2.15 billion.
Valuation measures for Vera Therapeutics, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.15B |
|---|---|
| Enterprise value | $2.23B |
| Price / book | 5.28 |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Vera Therapeutics, Inc. Class A Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$401.89M |
| EPS (TTM) | -$5.86 |
|---|
| Return on equity | -98.56% |
|---|
| Cash | $48.88M |
|---|
Range and volume for VERA over the past 52 weeks.
| 52-week high | $56.05 |
|---|---|
| 52-week low | $23.05 |
| Volume | 996.6K |
| Average volume | 2.19M |
| Previous close | $29.73 |
Invest a chosen dollar amount in Vera Therapeutics, Inc. Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell VERA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.